End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions.
about
Systemic nutritional interventions for treating foot ulcers in people with diabetesPentoxifylline for diabetic kidney diseaseHeparin and related substances for preventing diabetic kidney diseaseEducation programmes for people with diabetic kidney diseaseEducation programmes for people with diabetic kidney diseasePentoxifylline for diabetic kidney diseaseThe Incidence of End-Stage Renal Disease in the Diabetic (Compared to the Non-Diabetic) Population: A Systematic ReviewRole of T cells in type 2 diabetic nephropathyNovel role of parathyroid hormone-related protein in the pathophysiology of the diabetic kidney: evidence from experimental and human diabetic nephropathyDiabetic nephropathy and extracellular matrixN-acetyl-seryl-aspartyl-lysyl-proline: a valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetesDiabetic kidney disease: from physiology to therapeuticsDiabetes and end-stage renal disease; a review article on new conceptsUpdate on the treatment of type 2 diabetes mellitusDiabetic Kidney Disease: Pathophysiology and Therapeutic TargetsRAGE and CYBA polymorphisms are associated with microalbuminuria and end-stage renal disease onset in a cohort of type 1 diabetes mellitus patients over a 20-year follow-upDiabetic nephropathy - Epidemiology in Asia and the current state of treatmentGenome-wide association with diabetes-related traits in the Framingham Heart StudyCorrelation of enhanced thrombospondin-1 expression, TGF-beta signalling and proteinuria in human type-2 diabetic nephropathy.Renal lesions in patients with type 2 diabetes: a puzzle waiting to be solved.Inter-practice variation in diagnosing hypertension and diabetes mellitus: a cross-sectional study in general practice.Grape seed powder improves renal failure of chronic kidney disease patients.Paeoniflorin prevents diabetic nephropathy in rats.Diabetic Kidney Disease: A Syndrome Rather Than a Single Disease.Altered retinoic acid metabolism in diabetic mouse kidney identified by O isotopic labeling and 2D mass spectrometry.Effects of Low-Molecular-Weight Fucoidan and High Stability Fucoxanthin on Glucose Homeostasis, Lipid Metabolism, and Liver Function in a Mouse Model of Type II Diabetes.Association of serum bilirubin levels with development and progression of albuminuria, and decline in estimated glomerular filtration rate in patients with type 2 diabetes mellitus.Study of Neutrophil-lymphocyte Ratio as Novel Marker for Diabetic Nephropathy in Type 2 Diabetes.Screening for Chronic Kidney Disease in Adult Males in Vojvodina: A Cross-sectional Study.The protective effect of fucoidan in rats with streptozotocin-induced diabetic nephropathy.All-Cause Mortality Risk in Australian Women with Impaired Fasting Glucose and DiabetesPrevalence of microalbuminuria and risk factor analysis in type 2 diabetes patients in Albania: the need for accurate and early diagnosis of diabetic nephropathy.Inflammation in diabetic kidney diseaseN-glycosylation of carnosinase influences protein secretion and enzyme activity: implications for hyperglycemiaCost-effectiveness of angiotensin-converting enzyme inhibitors for the prevention of diabetic nephropathy in The Netherlands--a Markov model.Angiogenesis and chronic kidney disease.Renal protective potential of antihypertensive drugs.Effect of benfotiamine on advanced glycation endproducts and markers of endothelial dysfunction and inflammation in diabetic nephropathyBiochemistry and clinical role of human cystatin C.[Profile of diabetic in chronic hemodialysis: a multicenter study in Morocco]
P2860
Q24188236-72134484-6903-4527-845F-935CCF7EDBA9Q24203643-57C04600-07CC-4AEC-BB1E-F33BFA997CF8Q24235372-15E75F89-746B-4D57-B7DF-5D4955C7E8E0Q24236347-34B2FF02-2A5F-4C1F-BB02-47DC2511E5DDQ24241653-EE0A51BD-0F69-438D-BEFC-EBB2FD539B14Q24243734-D5DDDC60-50FE-4201-954B-F9D5EC58687BQ26774377-6F2900E4-A0D3-4F08-BE29-D4123B04117EQ26849691-6D158A2A-71FF-459B-B52C-D64A1168712DQ26862757-B0F7C9BB-48A9-4974-94DD-F28691C22934Q26996008-3D5C6731-A116-49F4-ACF8-2CE61A31D24CQ27008887-352136FB-9E6B-47B0-A904-6A908A8E1378Q27021392-54046064-536F-443E-B80C-9C24EE07CEA3Q27023025-CEFB40E5-D949-47D3-861F-507A276ACE73Q28073342-9F77F42A-56EA-4AF3-B116-15B2935876B2Q28086840-7040D23D-A8EF-4DB0-9F1E-8268A48C14C9Q28270272-E83E7690-FCF3-4DBE-A0B6-7145C9F27C55Q28742785-7A6A7422-1CE3-4DDC-8E62-86EA14727797Q33300811-5BF1D3E8-950A-45D8-AAF7-AF28309B1E22Q33357230-41C78411-8CD5-46F0-B0BE-F42C4D1152D4Q33359672-94949749-6003-4DA3-95EC-3E51C02DF156Q33401681-0AB43FB7-B1DF-46F9-AB46-42D4947A45D3Q33436604-3EE61C30-A78B-417F-AEA0-C74400EB8CF7Q33560342-BE0BD466-1BD0-4190-A194-2290DAE4D198Q33583012-F61EC122-0738-4281-BC6A-08A16958625DQ33608656-3973F4CA-E575-4560-8055-F74D5D140E6EQ33612248-17219D37-D070-41B9-B04C-DC955A0A26E2Q33622283-1C36B44E-8F05-49C5-BA4E-B280368A5E60Q33697462-896C875D-CE16-454C-9E75-21F1B484A396Q33801070-3EF0E702-B598-420E-9E67-31BFDCE02E1EQ33808925-29B78888-685C-4D94-B35A-9D3E50855945Q33862368-C7BAAA7F-1272-4FCA-8CB1-8401B9C94BD1Q33899286-086D5F00-E6F4-4089-A94F-38F78AC3050BQ34023543-518E758E-818F-477A-8B4A-ABC22FCC6A9EQ34024321-AF1D49DC-1C35-4CF4-8936-D351E261B781Q34056044-1497E17D-5F63-487A-9E9F-E1DAB7A38910Q34075013-13345D5B-5803-4985-9EAF-F5A2F9245A70Q34075168-E7F8F589-D2DF-469E-83FE-1E052ACD1D45Q34336244-F564179E-3FE6-4B8B-BD6E-110582FF86E6Q34377103-E8A826CD-8FF5-43D9-BB68-2AB85B60F5D5Q34444873-5289B4E6-F249-4B58-BB00-69629513E3A1
P2860
End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions.
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
End-stage renal failure in typ ...... rophe of worldwide dimensions.
@ast
End-stage renal failure in typ ...... rophe of worldwide dimensions.
@en
type
label
End-stage renal failure in typ ...... rophe of worldwide dimensions.
@ast
End-stage renal failure in typ ...... rophe of worldwide dimensions.
@en
prefLabel
End-stage renal failure in typ ...... rophe of worldwide dimensions.
@ast
End-stage renal failure in typ ...... rophe of worldwide dimensions.
@en
P2093
P1476
End-stage renal failure in typ ...... rophe of worldwide dimensions.
@en
P2093
P304
P356
10.1016/S0272-6386(99)70035-1
P577
1999-11-01T00:00:00Z